# Claroty

publishes a documented case study of an Italian pharmaceutical multinational securing critical production plans and maintaining regulatory compliance without interrupting production, alongside dedicated guidance on securing OT in pharmaceutical and biotechnology.


Source: https://cn.bioecon.ru/companies/claroty/
Updated: 2026-08-15

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2024年为510.1 million欧元 | https://blog.claroty.com/resources/case-studies/a-prescription-for-protection, https://claroty.com/resources/case-studies/a-prescription-for-protection, https://it.claroty.com/resources/case-studies/a-prescription-for-protection, https://social.claroty.com/resources/case-studies/a-prescription-for-protection, https://www.casestudies.com/company/claroty/case-study/fidia-farmaceutici-secures-1700-employee-operations-with-claroty-and-3-year-nis2-readiness |
| 产能 | 50 million/年，115 million/年，6 million/年，75 million/年，20 million贴片/年，35+ million毛巾/年，3+ million支唇膏/年 | https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |
| 认证 | ISO 14001、ISO 9001、ISO 13485、GMP、ISO 22716 | https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |
| 监管批准 | 获AIFA批准 | https://claroty.com/resources/case-studies/a-prescription-for-protection, https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |
| 生产基地 | Abano Terme（帕多瓦）、Noto（锡拉库萨）、Paderno Dugnano（米兰）、Monte Giberto（费尔莫） | https://www.fidiapharma.com/our-innovation/sites/, https://www.fidiapharma.com/wp-content/uploads/2025/05/Fidia-Consolidated-financial-statements-2024.pdf |
| 员工人数 | 全球员工1,700人 | https://blog.claroty.com/resources/case-studies/a-prescription-for-protection, https://claroty.com/resources/case-studies/a-prescription-for-protection, https://it.claroty.com/resources/case-studies/a-prescription-for-protection, https://social.claroty.com/resources/case-studies/a-prescription-for-protection, https://www.casestudies.com/company/claroty/case-study/fidia-farmaceutici-secures-1700-employee-operations-with-claroty-and-3-year-nis2-readiness, https://www.fidiapharma.ro/wp-content/uploads/2024/06/Corporate_Press_kit_ENG_MAY2024.pdf |
| 营收 | 2024年为510.1 million欧元 | https://blog.claroty.com/resources/case-studies/a-prescription-for-protection, https://claroty.com/resources/case-studies/a-prescription-for-protection, https://it.claroty.com/resources/case-studies/a-prescription-for-protection, https://social.claroty.com/resources/case-studies/a-prescription-for-protection, https://www.fidiapharma.ro/wp-content/uploads/2024/06/Corporate_Press_kit_ENG_MAY2024.pdf |

独立来源: casestudies.com, fidiapharma.com, fidiapharma.ro

## 技术

- [生物网络安全](https://cn.bioecon.ru/technology/bio-cybersecurity/)